547 related articles for article (PubMed ID: 17496199)
21. Master and servant: LINC00152 - a STAT3-induced long noncoding RNA regulates STAT3 in a positive feedback in human multiple myeloma.
Binder S; Zipfel I; Friedrich M; Riedel D; Ende S; Kämpf C; Wiedemann K; Buschmann T; Puppel SH; Reiche K; Stadler PF; Horn F
BMC Med Genomics; 2020 Feb; 13(1):22. PubMed ID: 32041604
[TBL] [Abstract][Full Text] [Related]
22. Constitutive activation of Stat3 signaling confers resistance to apoptosis in human U266 myeloma cells.
Catlett-Falcone R; Landowski TH; Oshiro MM; Turkson J; Levitzki A; Savino R; Ciliberto G; Moscinski L; Fernández-Luna JL; Nuñez G; Dalton WS; Jove R
Immunity; 1999 Jan; 10(1):105-15. PubMed ID: 10023775
[TBL] [Abstract][Full Text] [Related]
23. Interleukin 6 upregulates myeloid cell leukemia-1 expression through a STAT3 pathway in cholangiocarcinoma cells.
Isomoto H; Kobayashi S; Werneburg NW; Bronk SF; Guicciardi ME; Frank DA; Gores GJ
Hepatology; 2005 Dec; 42(6):1329-38. PubMed ID: 16317687
[TBL] [Abstract][Full Text] [Related]
24. Emodin has a cytotoxic activity against human multiple myeloma as a Janus-activated kinase 2 inhibitor.
Muto A; Hori M; Sasaki Y; Saitoh A; Yasuda I; Maekawa T; Uchida T; Asakura K; Nakazato T; Kaneda T; Kizaki M; Ikeda Y; Yoshida T
Mol Cancer Ther; 2007 Mar; 6(3):987-94. PubMed ID: 17363492
[TBL] [Abstract][Full Text] [Related]
25. IL-6R/STAT3/miR-204 feedback loop contributes to cisplatin resistance of epithelial ovarian cancer cells.
Zhu X; Shen H; Yin X; Long L; Chen X; Feng F; Liu Y; Zhao P; Xu Y; Li M; Xu W; Li Y
Oncotarget; 2017 Jun; 8(24):39154-39166. PubMed ID: 28388577
[TBL] [Abstract][Full Text] [Related]
26. Inhibition of constitutive STAT3 activity sensitizes resistant non-Hodgkin's lymphoma and multiple myeloma to chemotherapeutic drug-mediated apoptosis.
Alas S; Bonavida B
Clin Cancer Res; 2003 Jan; 9(1):316-26. PubMed ID: 12538484
[TBL] [Abstract][Full Text] [Related]
27. Kaposi's sarcoma herpesvirus (KSHV) microRNA K12-1 functions as an oncogene by activating NF-κB/IL-6/STAT3 signaling.
Chen M; Sun F; Han L; Qu Z
Oncotarget; 2016 May; 7(22):33363-73. PubMed ID: 27166260
[TBL] [Abstract][Full Text] [Related]
28. Regulation of Bcl-2-family proteins in myeloma cells by three myeloma survival factors: interleukin-6, interferon-alpha and insulin-like growth factor 1.
Jourdan M; De Vos J; Mechti N; Klein B
Cell Death Differ; 2000 Dec; 7(12):1244-52. PubMed ID: 11175262
[TBL] [Abstract][Full Text] [Related]
29. Signal Transducer and Activator of Transcription 3/MicroRNA-21 Feedback Loop Contributes to Atrial Fibrillation by Promoting Atrial Fibrosis in a Rat Sterile Pericarditis Model.
Huang Z; Chen XJ; Qian C; Dong Q; Ding D; Wu QF; Li J; Wang HF; Li WH; Xie Q; Cheng X; Zhao N; Du YM; Liao YH
Circ Arrhythm Electrophysiol; 2016 Jul; 9(7):e003396. PubMed ID: 27406600
[TBL] [Abstract][Full Text] [Related]
30. Co-activator SRC-1 is dispensable for transcriptional control by STAT3.
Cvijic H; Bauer K; Löffler D; Pfeifer G; Blumert C; Kretzschmar AK; Henze C; Brocke-Heidrich K; Horn F
Biochem J; 2009 Apr; 420(1):123-32. PubMed ID: 19203349
[TBL] [Abstract][Full Text] [Related]
31. Inhibition of JAK1/STAT3 signaling mediates compound K-induced apoptosis in human multiple myeloma U266 cells.
Park S; Lee HJ; Jeong SJ; Song HS; Kim M; Lee HJ; Lee EO; Kim DH; Ahn KS; Kim SH
Food Chem Toxicol; 2011 Jun; 49(6):1367-72. PubMed ID: 21420464
[TBL] [Abstract][Full Text] [Related]
32. Inhibition of miR-21 restores RANKL/OPG ratio in multiple myeloma-derived bone marrow stromal cells and impairs the resorbing activity of mature osteoclasts.
Pitari MR; Rossi M; Amodio N; Botta C; Morelli E; Federico C; Gullà A; Caracciolo D; Di Martino MT; Arbitrio M; Giordano A; Tagliaferri P; Tassone P
Oncotarget; 2015 Sep; 6(29):27343-58. PubMed ID: 26160841
[TBL] [Abstract][Full Text] [Related]
33. Paeoniflorin inhibits human gastric carcinoma cell proliferation through up-regulation of microRNA-124 and suppression of PI3K/Akt and STAT3 signaling.
Zheng YB; Xiao GC; Tong SL; Ding Y; Wang QS; Li SB; Hao ZN
World J Gastroenterol; 2015 Jun; 21(23):7197-207. PubMed ID: 26109806
[TBL] [Abstract][Full Text] [Related]
34. Inhibitory effect of baicalein on IL-6-mediated signaling cascades in human myeloma cells.
Liu S; Ma Z; Cai H; Li Q; Rong W; Kawano M
Eur J Haematol; 2010 Feb; 84(2):137-44. PubMed ID: 19878271
[TBL] [Abstract][Full Text] [Related]
35. Formononetin-induced oxidative stress abrogates the activation of STAT3/5 signaling axis and suppresses the tumor growth in multiple myeloma preclinical model.
Kim C; Lee SG; Yang WM; Arfuso F; Um JY; Kumar AP; Bian J; Sethi G; Ahn KS
Cancer Lett; 2018 Sep; 431():123-141. PubMed ID: 29857127
[TBL] [Abstract][Full Text] [Related]
36. Long noncoding RNA UCA1 regulates proliferation and apoptosis in multiple myeloma by targeting miR-331-3p/IL6R axis for the activation of JAK2/STAT3 pathway.
Li JL; Liu XL; Guo SF; Yang Y; Zhu YL; Li JZ
Eur Rev Med Pharmacol Sci; 2019 Nov; 23(21):9238-9250. PubMed ID: 31773675
[TBL] [Abstract][Full Text] [Related]
37. Potential crosstalk of the interleukin-6-heme oxygenase-1-dependent mechanism involved in resistance to lenalidomide in multiple myeloma cells.
Wu W; Ma D; Wang P; Cao L; Lu T; Fang Q; Zhao J; Wang J
FEBS J; 2016 Mar; 283(5):834-49. PubMed ID: 26700310
[TBL] [Abstract][Full Text] [Related]
38. Association and contribution of ERK to IL-6-induced activation of signal transducer and activator of transcription in a human myeloma cell line.
Song L; Shen B; Li Y
Chin Med J (Engl); 2001 Sep; 114(9):954-7. PubMed ID: 11780390
[TBL] [Abstract][Full Text] [Related]
39. miR-146a suppresses STAT3/VEGF pathways and reduces apoptosis through IL-6 signaling in primary human retinal microvascular endothelial cells in high glucose conditions.
Ye EA; Steinle JJ
Vision Res; 2017 Oct; 139():15-22. PubMed ID: 28433754
[TBL] [Abstract][Full Text] [Related]
40. In the presence of bone marrow stromal cells human multiple myeloma cells become independent of the IL-6/gp130/STAT3 pathway.
Chatterjee M; Hönemann D; Lentzsch S; Bommert K; Sers C; Herrmann P; Mathas S; Dörken B; Bargou RC
Blood; 2002 Nov; 100(9):3311-8. PubMed ID: 12384432
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
